Experimental drug shows promise in treating marijuana addiction.
An experimental drug called AEF-0117 has shown positive results in reducing the addictive impact of THC on the brain in a small trial of 29 adult men and women diagnosed with cannabis-use disorder. The drug was said to reduce the "good effects" weed had on some participants in the trial by 38%. Currently, there is no FDA-approved medication on the market to treat cannabis-use disorder. A larger study of 300 patients will be conducted to back up the small trial's success. Cannabis addiction is prevalent particularly among younger consumers.